Gram Negative Identification Panel,Susceptibility Test Cards, Antimicrobial,Inst
Gram Negative Identification Panel,Susceptibility Test Cards, Antimicrobial,Instrument For Auto Reader & Interpretation Of Overnight Suscept. Systems,Manual Antimicrobial Susceptibility Test Systems,Panels, Test, Susceptibility, Antimicrobial
Gram Negative Identification Panel,Susceptibility Test Cards, Antimicrobial,Inst
Gram Negative Identification Panel,Susceptibility Test Cards, Antimicrobial,Instrument For Auto Reader & Interpretation Of Overnight Suscept. Systems,Manual Antimicrobial Susceptibility Test Systems,Panels, Test, Susceptibility, Antimicrobial
Manual Antimicrobial Susceptibility Test Systems,Instrument For Auto Reader & In
Manual Antimicrobial Susceptibility Test Systems,Instrument For Auto Reader & Interpretation Of Overnight Suscept. Systems,Panels, Test, Susceptibility, Antimicrobial,Susceptibility Test Cards, Antimicrobial,Gram Negative Identification Panel
Gram Negative Identification Panel,Susceptibility Test Cards, Antimicrobial,Pane
Gram Negative Identification Panel,Susceptibility Test Cards, Antimicrobial,Panels, Test, Susceptibility, Antimicrobial,Instrument For Auto Reader & Interpretation Of Overnight Suscept. Systems,Manual Antimicrobial Susceptibility Test Systems
The Access SARS-CoV-2 IgG II Calibrators are intended to calibrate the Access SA
The Access SARS-CoV-2 IgG II Calibrators are intended to calibrate the Access SARS-CoV-2 IgG II assay for the in vitro semi-quantitative and qualitative detection of SARS-CoV-2 IgG antibodies in human plasma (lithium heparin, dipotassium EDTA, tripotassium EDTA, and sodium citrate) for use on the Access Immunoassay Systems only.The Access SARS-CoV-2 IgG II calibrators are only for use under the Food and Drug Administration's Emergency Use Authorization.
The Access Toxo IgG QC is intended for monitoring system performance of the Acce
The Access Toxo IgG QC is intended for monitoring system performance of the Access Toxo IgG assay.
The Access CEA QC (BSA matrix) controls are intended for monitoring the system p
The Access CEA QC (BSA matrix) controls are intended for monitoring the system performance of immunoenzymatic procedures for the quantitative measurement of Carcinoembryonic Antigen (CEA) using Access CEA reagents.
The Cannabinoid assay is an in vitro diagnostic reagent for the qualitative and
The Cannabinoid assay is an in vitro diagnostic reagent for the qualitative and semi-quantitative analysis of Cannabinoids (THC) in human urine.
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine. They are competitive enzyme immunoassays.
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the
The Evidence® Drugs of Abuse (DOA) Assays are in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine. They are competitive enzyme immunoassays.
Identify Health Drug Screen Test CupAMP500/BAR300/BUP10/BZO300/COC150/MDMA500/ME
Identify Health Drug Screen Test CupAMP500/BAR300/BUP10/BZO300/COC150/MDMA500/MET500/MTD300/OPI300/OXY100/TCA1000/THC50